0001526947-13-000003.txt : 20131113 0001526947-13-000003.hdr.sgml : 20131113 20131113161209 ACCESSION NUMBER: 0001526947-13-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20131113 DATE AS OF CHANGE: 20131113 EFFECTIVENESS DATE: 20131113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresight Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001526947 IRS NUMBER: 262540398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-206282 FILM NUMBER: 131214739 BUSINESS ADDRESS: STREET 1: 50 WEST 57TH STREET STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 6467479100 MAIL ADDRESS: STREET 1: 50 WEST 57TH STREET STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 D 1 primary_doc.xml X0707 D LIVE 0001526947 Foresight Biotherapeutics, Inc. 50 WEST 57TH STREET 15TH FLOOR NEW YORK NY NEW YORK 10019 6467479100 DELAWARE None None Corporation true Michael Weiser 50 West 57th Street 15th Floor New York NY NEW YORK 10019 Executive Officer Director Jason Stein 50 West 57th Street 15th Floor New York NY NEW YORK 10019 Executive Officer Director Stephen Rocamboli 50 West 57th Street 15th Floor New York NY NEW YORK 10019 Director Biotechnology Decline to Disclose 06c false 2013-10-30 false true true true false 15000000 15000000 15000000 0 false 2 0 0 0 false Foresight Biotherapeutics, Inc. Michael Weiser Michael Weiser Vice President 2013-11-13